全文获取类型
收费全文 | 2906篇 |
免费 | 97篇 |
国内免费 | 205篇 |
专业分类
儿科学 | 39篇 |
妇产科学 | 3篇 |
基础医学 | 291篇 |
口腔科学 | 3篇 |
临床医学 | 357篇 |
内科学 | 808篇 |
皮肤病学 | 18篇 |
神经病学 | 13篇 |
特种医学 | 363篇 |
外科学 | 746篇 |
综合类 | 228篇 |
预防医学 | 52篇 |
眼科学 | 2篇 |
药学 | 85篇 |
中国医学 | 17篇 |
肿瘤学 | 183篇 |
出版年
2023年 | 35篇 |
2022年 | 77篇 |
2021年 | 86篇 |
2020年 | 77篇 |
2019年 | 79篇 |
2018年 | 76篇 |
2017年 | 53篇 |
2016年 | 103篇 |
2015年 | 74篇 |
2014年 | 175篇 |
2013年 | 140篇 |
2012年 | 130篇 |
2011年 | 157篇 |
2010年 | 154篇 |
2009年 | 172篇 |
2008年 | 147篇 |
2007年 | 178篇 |
2006年 | 160篇 |
2005年 | 121篇 |
2004年 | 105篇 |
2003年 | 83篇 |
2002年 | 79篇 |
2001年 | 88篇 |
2000年 | 61篇 |
1999年 | 51篇 |
1998年 | 44篇 |
1997年 | 51篇 |
1996年 | 41篇 |
1995年 | 31篇 |
1994年 | 35篇 |
1993年 | 32篇 |
1992年 | 29篇 |
1991年 | 49篇 |
1990年 | 24篇 |
1989年 | 32篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 12篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1974年 | 6篇 |
1969年 | 5篇 |
1967年 | 6篇 |
排序方式: 共有3208条查询结果,搜索用时 15 毫秒
1.
《Morphologie : bulletin de l'Association des anatomistes》2022,106(353):136-140
2.
《European journal of surgical oncology》2022,48(4):707-717
BackgroundChyle leak (CL) is a clinically relevant complication after pancreatectomy. Its incidence and the associated risk factors are ill defined, and various treatments options have been described. There is no consensus, however, regarding optimal management. The present study aims to systematically review the literature on CL after pancreatectomy.MethodsA systematic review from PubMed, Scopus and Embase database was performed. Studies using a clear definition for CL and published from January 2000 to January 2021 were included. The PRISMA guidelines were followed during all stages of this systematic review. The MINORS score was used to assess methodological quality.ResultsLiterature search found 361 reports, 99 of which were duplicates. The titles and abstracts of 262 articles were finally screened. The references from the remaining 181 articles were manually assessed. After the exclusions, 43 articles were thoroughly assessed. A total of 23 articles were ultimately included for this review. The number of patients varied from 54 to 3532. Incidence of post pancreatectomy CL varied from 1.3% to 22.1%. Main risk factors were the extent of the surgery and early oral or enteral feeding. CL dried up spontaneously or after conservative management within 14 days in 53% to 100% of the cases.ConclusionsThe extent of surgery is the most common predictor of risk of CL. Conservative treatment has been shown to be effective in most cases and can be considered the treatment of choice. We propose a management algorithm based on the current available evidence. 相似文献
3.
4.
中医学古籍中罕有关于“胰腺”的明确记载,缺乏直观、系统的理论论述。本文试图通过对各个时期具有代表性的医学典籍所记载内容的分析,结合现代解剖学相关理论,梳理中医学对胰腺实体解剖的认识过程。通过分析,笔者认为中医学对胰腺实体解剖的认识具有阶段性:①先秦两汉时期,存在胰腺实体解剖,但并非认为胰腺是脏器;②唐宋时期,胰腺实体解剖更加清晰,在医学上胰腺附属于脾,并非为独立的脏器;③明清时期,胰腺实体解剖明确,部分医家以独立脏器论之,出现“脾”、“胰”之争。中医学理论缺少对胰腺的单独论述,目前学界的主流观点多为“胰属脾”,线性归属以脾笼统代之略显单薄,不利于理论的丰富与发展。笔者认为胰腺藏象应独立于脾单独讨论,现代解剖学对胰腺命名同一,形态结构清楚,位置描述明确,可直接补充进中医学胰腺藏象(藏)理论中,为完善胰腺藏象理论搭建解剖学基础。 相似文献
5.
Luis Fernando Calimano-Ramirez Taher Daoud Dheeraj Reddy Gopireddy Ajaykumar C Morani Rebecca Waters Kazim Gumus Albert Russell Klekers Priya R Bhosale Mayur K Virarkar 《World journal of gastroenterology : WJG》2022,28(40):5827-5844
Acinar cell carcinoma (ACC) is a rare pancreatic malignancy with distinctive clinical, molecular, and morphological features. The long-term survival of ACC patients is substantially superior to that of pancreatic adenocarcinoma patients. As there are no significant patient series about ACCs, our understanding of this illness is mainly based on case reports and limited patient series. Surgical resection is the treatment of choice for patients with the disease restricted to one organ; however, with recent breakthroughs in precision medicine, medicines targeting the one-of-a-kind molecular profile of ACC are on the horizon. There are no standard treatment protocols available for people in which a total surgical resection to cure the condition is not possible. As a result of shared genetic alterations, ACCs are chemosensitive to agents with activity against pancreatic adenocarcinomas and colorectal carcinomas. The role of neoadjuvant or adjuvant chemoradiotherapy has not been established. This article aims to do a comprehensive literature study and present the most recent information on acinar cell cancer. 相似文献
6.
7.
《Cirugía espa?ola》2021,99(8):593-601
IntroductionLaparoscopic pancreaticoduodenectomy (PD) is not widely accepted, and its use is controversial. Only correct patient selection and appropriate training of groups experienced in pancreatic surgery and laparoscopy will be able to establish its role and its hypothetical advantagesMethodsOut of 138 pancreatic surgeries performed in a two-year period (2017-2019), 23 were laparoscopic PD. We evaluate its efficacy and safety compared to 31 open PD.ResultsThere were no cases of B/C pancreatic or biliary fistula, nor any cases of delayed gastric emptying in the laparoscopic group, but hemorrhage required one reoperation. The conversion rate was 21% (five cases): one due to bleeding, and the remainder for non-progression. The converted patients showed no differences compared to those completed by laparoscopy. There were no differences between laparoscopic and open PD in surgical time, postoperative complications, reintervention rate, readmissions or mortality. R0 resection in tumor cases was 85% for laparoscopy and 69% in open surgery without statistical significance. The postoperative hospital stay was shorter in the laparoscopic PD group (eight vs. 15 days).ConclusionsIn a selected group, laparoscopic PD can be safely and effectively performed if carried out by groups who are experts in pancreatic surgery and advanced laparoscopy. The technique has the same postoperative results as open surgery and is oncologically adequate, with less hospital stay. Proper patient selection, a step-by-step program and a lax and early conversion prevents serious operating accidents. 相似文献
8.
9.
Marco Del Chiaro Caroline Verbeke 《World journal of gastrointestinal pathophysiology》2015,6(2):29-32
Pancreatic cystic neoplasms(PCNs) are a high prevalence disease. It is estimated that about 20% of the general population is affected by PCNs. Some of those lesions can progress till cancer, while others behave in a benign fashion. In particular intraductal papillary mucinousneoplasms of the pancreas can be considered as the pancreatic analogon to colonic polyps. Treatment of these precursor lesions at an early stage can potentially reduce pancreas cancer mortality and introduce a new "era" of preemptive pancreatic surgery. However, only few of those lesions have an aggressive behavior. The accuracy of preoperative diagnosis, i.e., the distinction between the various PCNs is around 60%, and the ability to predict the future outcome is also less accurate. For this reason, a significant number of patients are currently over-treated with an unnecessary, high-risk surgery. Furthermore, the majority of patients with PCN are on life-long follow-up with imaging modality, which has huge cost implications for the Health Care System for limited benefits considering that a significant proportion of PCNs are or behave like benign lesions. The current guidelines for the diagnosis and management of PCNs are more based on expert opinion than on evidence. For all those reasons, the management of cystic tumors of the pancreas remains a controversial area of pancreatology. On one hand, the detection of PCNs and the surgical treatment of pre-cancerous neoplasms can be considered a big opportunity to reduce pancreatic cancer related mortality. On the other hand, PCNs are associated with a considerable risk of under- or over- treatment of patients and incur high costs for the Health Care System. 相似文献
10.